Nanopharmaceuticals Market

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their ?bulk? counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
Nanopharmaceuticals Market contains market size and forecasts of Nanopharmaceuticals in global, including the following market information:
Global Nanopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nanopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Nanopharmaceuticals companies in 2021 (%)
The global Nanopharmaceuticals market was valued at 31860 million in 2021 and is projected to reach US$ 72390 million by 2028, at a CAGR of 12.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanopharmaceuticals include Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly and Astrazeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Global Nanopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
Global Nanopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Nanopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nanopharmaceuticals revenues share in global market, 2021 (%)
Key companies Nanopharmaceuticals sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Nanopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy